Peer-reviewed clinical validation, strengthened balance sheet, and disciplined execution position the Company for 2026 SHELTON, Conn., Jan. 13, 2026 /PRNewswire/ -- ...

Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using ...

Auctioneer Grant Burns described Segenhoe Stud’s son of Frankel as “a seven-figure colt all day long,” and that prediction ...

At least four people were killed in a massive Russian aerial assault on Ukraine involving nearly 300 drones and dozens of ...